n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Carcinoma, Epidermoid

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhattacharya, N; Costello, R; DeRosa, C; Faucher, J; Haddad, RI; Latham, VM; Loda, M; Miller, LP; Oster, MW; Posner, MR; Raftopoulos, H; Shapiro, GI; Weinstein, LJ; Wieczorek, TJ; Yule, M; Zhang, X	1

Trials

1 trial(s) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Carcinoma, Epidermoid

Article	Year
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-15, Volume: 10, Issue:14 Topics: Aged; Aged, 80 and over; Anemia; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Patient Dropouts; Phosphorylation; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Sulfonamides; Thrombocytopenia; Treatment Outcome	2004

Article

Year

A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-15, Volume: 10, Issue:14

Topics: Aged; Aged, 80 and over; Anemia; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Patient Dropouts; Phosphorylation; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Sulfonamides; Thrombocytopenia; Treatment Outcome

2004